4-2829656-T-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001122681.2(SH3BP2):​c.750T>G​(p.Ala250Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.496 in 1,611,582 control chromosomes in the GnomAD database, including 200,283 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A250A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.47 ( 17057 hom., cov: 29)
Exomes 𝑓: 0.50 ( 183226 hom. )

Consequence

SH3BP2
NM_001122681.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10O:1

Conservation

PhyloP100: -0.742

Publications

25 publications found
Variant links:
Genes affected
SH3BP2 (HGNC:10825): (SH3 domain binding protein 2) The protein encoded by this gene has an N-terminal pleckstrin homology (PH) domain, an SH3-binding proline-rich region, and a C-terminal SH2 domain. The protein binds to the SH3 domains of several proteins including the ABL1 and SYK protein tyrosine kinases , and functions as a cytoplasmic adaptor protein to positively regulate transcriptional activity in T, natural killer (NK), and basophilic cells. Mutations in this gene result in cherubism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
SH3BP2 Gene-Disease associations (from GenCC):
  • cherubism
    Inheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 4-2829656-T-G is Benign according to our data. Variant chr4-2829656-T-G is described in ClinVar as Benign. ClinVar VariationId is 258898.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.742 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.567 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SH3BP2NM_001122681.2 linkc.750T>G p.Ala250Ala synonymous_variant Exon 8 of 13 ENST00000503393.8 NP_001116153.1
SH3BP2NM_001145856.2 linkc.921T>G p.Ala307Ala synonymous_variant Exon 8 of 13 NP_001139328.1
SH3BP2NM_001145855.2 linkc.834T>G p.Ala278Ala synonymous_variant Exon 8 of 13 NP_001139327.1
SH3BP2NM_003023.4 linkc.750T>G p.Ala250Ala synonymous_variant Exon 8 of 13 NP_003014.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SH3BP2ENST00000503393.8 linkc.750T>G p.Ala250Ala synonymous_variant Exon 8 of 13 1 NM_001122681.2 ENSP00000422168.3

Frequencies

GnomAD3 genomes
AF:
0.470
AC:
70975
AN:
151152
Hom.:
17042
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.376
Gnomad AMI
AF:
0.622
Gnomad AMR
AF:
0.577
Gnomad ASJ
AF:
0.491
Gnomad EAS
AF:
0.470
Gnomad SAS
AF:
0.559
Gnomad FIN
AF:
0.454
Gnomad MID
AF:
0.528
Gnomad NFE
AF:
0.494
Gnomad OTH
AF:
0.475
GnomAD2 exomes
AF:
0.509
AC:
127187
AN:
250048
AF XY:
0.509
show subpopulations
Gnomad AFR exome
AF:
0.375
Gnomad AMR exome
AF:
0.642
Gnomad ASJ exome
AF:
0.482
Gnomad EAS exome
AF:
0.447
Gnomad FIN exome
AF:
0.458
Gnomad NFE exome
AF:
0.494
Gnomad OTH exome
AF:
0.515
GnomAD4 exome
AF:
0.499
AC:
728086
AN:
1460314
Hom.:
183226
Cov.:
50
AF XY:
0.500
AC XY:
363530
AN XY:
726488
show subpopulations
African (AFR)
AF:
0.371
AC:
12432
AN:
33468
American (AMR)
AF:
0.635
AC:
28399
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.487
AC:
12722
AN:
26116
East Asian (EAS)
AF:
0.461
AC:
18300
AN:
39698
South Asian (SAS)
AF:
0.564
AC:
48652
AN:
86240
European-Finnish (FIN)
AF:
0.462
AC:
24312
AN:
52598
Middle Eastern (MID)
AF:
0.517
AC:
2978
AN:
5764
European-Non Finnish (NFE)
AF:
0.495
AC:
550238
AN:
1111362
Other (OTH)
AF:
0.498
AC:
30053
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
20137
40274
60411
80548
100685
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16112
32224
48336
64448
80560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.470
AC:
71021
AN:
151268
Hom.:
17057
Cov.:
29
AF XY:
0.473
AC XY:
34933
AN XY:
73864
show subpopulations
African (AFR)
AF:
0.376
AC:
15498
AN:
41194
American (AMR)
AF:
0.577
AC:
8782
AN:
15212
Ashkenazi Jewish (ASJ)
AF:
0.491
AC:
1700
AN:
3464
East Asian (EAS)
AF:
0.469
AC:
2378
AN:
5068
South Asian (SAS)
AF:
0.558
AC:
2665
AN:
4772
European-Finnish (FIN)
AF:
0.454
AC:
4752
AN:
10472
Middle Eastern (MID)
AF:
0.537
AC:
158
AN:
294
European-Non Finnish (NFE)
AF:
0.494
AC:
33518
AN:
67782
Other (OTH)
AF:
0.478
AC:
1005
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
1876
3752
5627
7503
9379
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
656
1312
1968
2624
3280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.487
Hom.:
69013
Bravo
AF:
0.475
Asia WGS
AF:
0.528
AC:
1835
AN:
3478
EpiCase
AF:
0.496
EpiControl
AF:
0.492

ClinVar

Significance: Benign
Submissions summary: Benign:10Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Fibrous dysplasia of jaw Benign:5
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 28, 2017
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:3
Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 85% of patients studied by a panel of primary immunodeficiencies. Number of patients: 82. Only high quality variants are reported. -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2Other:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
2.3
DANN
Benign
0.35
PhyloP100
-0.74
PromoterAI
0.0036
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs231399; hg19: chr4-2831383; COSMIC: COSV62553745; COSMIC: COSV62553745; API